175 related articles for article (PubMed ID: 1797419)
1. Research for new antichagasic drugs.
Mester B; Claramunt RM; Elguero J; Atienza J; Gómez Barrio A; Escario JA
Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):1990-3. PubMed ID: 1797419
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro and in silico studies of 1H- and 2H-1,2,3-triazoles as antichagasic agents.
Silva TB; Ji KNK; Petzold Pauli F; Galvão RMS; Faria AFM; Bello ML; Resende JALC; Campos VR; Forezi LDSM; da Silva FC; Faria RX; Ferreira VF
Bioorg Chem; 2021 Nov; 116():105250. PubMed ID: 34469833
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological in vitro and in vivo Evaluation of 2-(5-Nitroindazol-1-yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas Disease.
Martín-Escolano R; Aguilera-Venegas B; Marín C; Martín-Montes Á; Martín-Escolano J; Medina-Carmona E; Arán VJ; Sánchez-Moreno M
ChemMedChem; 2018 Oct; 13(19):2104-2118. PubMed ID: 30098232
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of anti-Trypanosoma cruzi compounds on HSP60 levels.
Muelas-Serrano S; Pérez-Serrano J; Gómez-Barrio A; Ochoa C; Martínez J; Rodríguez-Caabeiro F
Parasitol Res; 2001 Aug; 87(8):615-8. PubMed ID: 11510996
[TBL] [Abstract][Full Text] [Related]
5. Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives.
Wilkinson SR; Bot C; Kelly JM; Hall BS
Curr Top Med Chem; 2011; 11(16):2072-84. PubMed ID: 21619510
[TBL] [Abstract][Full Text] [Related]
6. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
Cabrera E; Murguiondo MG; Arias MG; Arredondo C; Pintos C; Aguirre G; Fernández M; Basmadjián Y; Rosa R; Pacheco JP; Raymondo S; Di Maio R; González M; Cerecetto H
Eur J Med Chem; 2009 Oct; 44(10):3909-14. PubMed ID: 19446929
[TBL] [Abstract][Full Text] [Related]
7. Anti-T. cruzi agents: our experience in the evaluation of more than five hundred compounds.
Cerecetto H; González M
Mini Rev Med Chem; 2008 Nov; 8(13):1355-83. PubMed ID: 18991753
[TBL] [Abstract][Full Text] [Related]
8. Indazoles: a new top seed structure in the search of efficient drugs against Trypanosoma cruzi.
Aguilera-Venegas B; Olea-Azar C; Arán VJ; Speisky H
Future Med Chem; 2013 Oct; 5(15):1843-59. PubMed ID: 24144415
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug.
Vega MC; Rolón M; Montero-Torres A; Fonseca-Berzal C; Escario JA; Gómez-Barrio A; Gálvez J; Marrero-Ponce Y; Arán VJ
Eur J Med Chem; 2012 Dec; 58():214-27. PubMed ID: 23124218
[TBL] [Abstract][Full Text] [Related]
10. [Nifurtimox, a bright future for treatment of Chagas disease].
Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M
Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868
[TBL] [Abstract][Full Text] [Related]
11. The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi.
de Castro SL
Acta Trop; 1993 Apr; 53(2):83-98. PubMed ID: 8098901
[TBL] [Abstract][Full Text] [Related]
12. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and molecular docking studies of novel N-arylsulfonyl-benzimidazoles with anti Trypanosoma cruzi activity.
Miana GE; Ribone SR; Vera DMA; Sánchez-Moreno M; Mazzieri MR; Quevedo MA
Eur J Med Chem; 2019 Mar; 165():1-10. PubMed ID: 30641409
[TBL] [Abstract][Full Text] [Related]
14. Natural and synthetic naphthoquinones active against Trypanosoma cruzi: an initial step towards new drugs for Chagas disease.
Salas CO; Faúndez M; Morello A; Maya JD; Tapia RA
Curr Med Chem; 2011; 18(1):144-61. PubMed ID: 21110810
[TBL] [Abstract][Full Text] [Related]
15. New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies.
Rodríguez J; Arán VJ; Boiani L; Olea-Azar C; Lavaggi ML; González M; Cerecetto H; Maya JD; Carrasco-Pozo C; Cosoy HS
Bioorg Med Chem; 2009 Dec; 17(24):8186-96. PubMed ID: 19900812
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antichagasic properties of new 1,2,6-thiadiazin-3,5-dione 1,1-dioxides and related compounds.
Di Maio R; Cerecetto H; Seoane G; Ochoa C; Arán VJ; Pérez E; Gómez Barrio A; Muelas S
Arzneimittelforschung; 1999 Sep; 49(9):759-63. PubMed ID: 10514904
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of Chagas' disease].
Apt W
Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
[No Abstract] [Full Text] [Related]
18. Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents.
Papadopoulou MV; Trunz BB; Bloomer WD; McKenzie C; Wilkinson SR; Prasittichai C; Brun R; Kaiser M; Torreele E
J Med Chem; 2011 Dec; 54(23):8214-23. PubMed ID: 22023653
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro evaluation, and SAR studies of a potential antichagasic 1H-pyrazolo[3,4-b]pyridine series.
Dias LR; Santos MB; Albuquerque Sd; Castro HC; de Souza AM; Freitas AC; DiVaio MA; Cabral LM; Rodrigues CR
Bioorg Med Chem; 2007 Jan; 15(1):211-9. PubMed ID: 17064907
[TBL] [Abstract][Full Text] [Related]
20. New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
Bollini M; Casal JJ; Alvarez DE; Boiani L; González M; Cerecetto H; Bruno AM
Bioorg Med Chem; 2009 Feb; 17(4):1437-44. PubMed ID: 19168363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
